Health Care & Life Sciences » Pharmaceuticals | KPC Pharmaceuticals Inc.

KPC Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
235,644.40
308,039.00
431,315.20
409,518.40
335,286.80
341,685.70
Depreciation, Depletion & Amortization
45,133.30
71,859.60
79,936.80
84,669.10
98,447.40
108,656
Other Funds
680,919.50
1,931.60
1,263,742.70
19,491.40
46,419.10
74,603.90
Funds from Operations
287,153.20
402,746.00
511,800.80
495,108.00
445,357.60
489,984.10
Changes in Working Capital
52,603.90
24,237.90
20,525.00
160,100.20
169,217.40
83,341.50
Net Operating Cash Flow
234,549.30
426,984.00
491,275.80
335,007.80
276,140.20
406,642.60
Capital Expenditures
212,654.50
233,086.50
210,817.40
203,451.60
228,567.80
Sale of Fixed Assets & Businesses
208.10
27.10
4,611.70
46,970.10
2,757.00
Purchase/Sale of Investments
978,600.00
239,502.60
1,386,604.30
119,376.60
52,955.70
Net Investing Cash Flow
726,138.10
17,243.20
1,835,567.50
71,312.80
239,177.40
Cash Dividends Paid - Total
94,252.80
119,395.60
57,992.10
161,681.20
141,964.00
Issuance/Reduction of Debt, Net
86,600.00
51,300.00
252,450.00
35,500.00
183,849.00
Net Financing Cash Flow
500,066.70
172,627.20
1,458,200.50
177,689.70
48,953.50
Net Change in Cash
8,474.20
271,189.70
113,492.30
89,025.10
15,764.30
Free Cash Flow
21,894.70
193,897.40
280,458.40
131,556.20
47,572.40
Deferred Taxes & Investment Tax Credit
1,003.40
900.60
16,406.40
7,998.60
46,198.60
34,961.40
Net Assets from Acquisitions
3,125.40
-
253,330.00
39,743.60
66,322.30
Other Sources
468,033.80
10,800.00
32,571.20
5,535.70
-
Change in Capital Stock
-
-
-
-
44,419.40
Exchange Rate Effect
3.70
410.30
416.50
3,019.80
3,773.60
Other Uses
-
-
21,998.70
-
-

About KPC Pharmaceuticals

View Profile
Address
No. 166 Keyi Road
Kunming Yunnan 650106
China
Employees -
Website http://www.kpc.com.cn
Updated 07/08/2019
KPC Pharmaceuticals, Inc. engages in the research and development, manufacture, sale, commercial wholesale, and international marketing of drugs. It focuses on natural herbal-based Chinese medicine, chemical medicine, and pharmaceutical area. Its products include panax notoginseng, gastrodine, artemether, and special botanical drugs.